These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12127081)

  • 21. Effect of serotonin on platelet function in cocaine exposed blood.
    Ziu E; Hadden C; Li Y; Lowery CL; Singh P; Ucer SS; Mercado CP; Gu HH; Kilic F
    Sci Rep; 2014 Aug; 4():5945. PubMed ID: 25091505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.
    Skop BP; Brown TM
    Psychosomatics; 1996; 37(1):12-6. PubMed ID: 8600488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake.
    Lopez-Vilchez I; Diaz-Ricart M; White JG; Escolar G; Galan AM
    Cardiovasc Res; 2009 Nov; 84(2):309-16. PubMed ID: 19541671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
    Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M
    J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infusion of fluoxetine, a serotonin reuptake inhibitor, in the shell region of the nucleus accumbens increases blood glucose concentrations in rats.
    Diepenbroek C; Rijnsburger M; Eggels L; van Megen KM; Ackermans MT; Fliers E; Kalsbeek A; Serlie MJ; la Fleur SE
    Neurosci Lett; 2017 Jan; 637():85-90. PubMed ID: 27888043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.
    Bismuth-Evenzal Y; Roz N; Gurwitz D; Rehavi M
    Biochem Pharmacol; 2010 Nov; 80(10):1546-52. PubMed ID: 20696140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates.
    Reikvam AG; Hustad S; Reikvam H; Apelseth TO; Nepstad I; Hervig TA
    Platelets; 2012; 23(4):299-308. PubMed ID: 22273511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation.
    Tseng YL; Chiang ML; Huang TF; Su KP; Lane HY; Lai YC
    Thromb Res; 2010 Dec; 126(6):517-23. PubMed ID: 20961601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.
    Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC
    Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of platelet mobilisation into lungs in response to 5-hydroxytryptamine (serotonin) in mice.
    Yu Z; Ohba M; Nakamura M; Sasano T; Ono M; Sugawara S; Endo Y
    Thromb Haemost; 2009 Dec; 102(6):1251-8. PubMed ID: 19967158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subacute fluoxetine enhances conditioned responding and conditioning-specific reflex modification of the rabbit nictitating membrane response: implications for drug treatment with selective serotonin reuptake inhibitors.
    Burhans LB; Smith-Bell CA; Schreurs BG
    Behav Pharmacol; 2013 Feb; 24(1):55-64. PubMed ID: 23263485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin reuptake inhibitor-related extrapyramidal side effects in two patients with cerebral palsy.
    Rone LA; Ferrando SJ
    Psychosomatics; 1996; 37(2):165-6. PubMed ID: 8742546
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet serotonin in newborns and infants: ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors.
    Anderson GM; Czarkowski K; Ravski N; Epperson CN
    Pediatr Res; 2004 Sep; 56(3):418-22. PubMed ID: 15240861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
    Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD
    Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trial.
    Kotzailias N; Andonovski T; Dukic A; Serebruany VL; Jilma B
    J Clin Pharmacol; 2006 Apr; 46(4):468-75. PubMed ID: 16554456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors.
    de Maistre E; Allart C; Lecompte T; Bollaert PE
    Am J Med; 2002 Oct; 113(6):530-2. PubMed ID: 12427509
    [No Abstract]   [Full Text] [Related]  

  • 39. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
    Tseng YL; Braun A; Chang JP; Chiang ML; Tseng CY; Chen W
    Toxicol Appl Pharmacol; 2019 Feb; 364():106-113. PubMed ID: 30592962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fluoxetine].
    Gleiter CH; Volz HP
    Dtsch Med Wochenschr; 1997 Apr; 122(15):481-2. PubMed ID: 9147940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.